The new law defines "cannabinoid edible products" as "soft or hard lozenges in a geometric square shape into which a cannabinoid concentrate or the dried leaves or flowers of the plant of the genus cannabis is incorporated." The post North Dakota: Governor Signs Legislation Authorizing Patients To Obtain Cannabis-Infused Edible Products appeared first on NORML.
"The individuals who are continuing to be opposed are absolutely disregarding the fact that 71 percent of people in this state support safe and regulated medical cannabis." The post Nebraska: Attorney General, Former Governor Urge Lawmakers to Ignore Medical Marijuana Legalization Vote appeared first on NORML.
"The results of this study indicate that cannabis may be a relatively safe and effective treatment for chronic pain, sleep disturbances, and other conditions associated with aging, leading to subsequent reductions in prescription drug use and healthcare costs, as well as significant improvements in quality of life." The post Study: Cannabis Use in Older Patients Associated With Improved Quality of Life, Lower Demand for Prescription Drugs appeared first on NORML.
"The current findings suggest [that] cannabis-based medicinal products may be effective in reducing suicidal ideation, as well as other facets of health and well-being." The post Study: Patients Less Likely To Have Suicidal Thoughts Following Medical Cannabis Use appeared first on NORML.
Statewide polling indicates that between 70 percent and 80 percent of Nebraskans support legalizing medical marijuana access. The post Nebraska: Voters To Decide on Medical Cannabis Access Measures appeared first on NORML.
Physicians already possess the discretion to prescribe any number of medications, like opioids, which pose far greater risks to health than marijuana. It is appropriate that health care providers possess the same freedom to make medical cannabis-related decisions as they do when choosing to authorize other therapeutic options for their patients. The post New Hampshire: Governor Signs Laws Significantly Expanding Medical Cannabis Access appeared first on NORML.
The new law provides discretion to physicians to issue medical cannabis recommendations to any patient who may benefit from it. It also allows those ages 65 or older to self-certify for a registration card absent a doctor’s recommendation. The post Delaware: Governor Signs Medical Cannabis Expansion Bill Into Law appeared first on NORML.
"While expediting timelines may seem advantageous, the potential negatives embedded within the bill outweigh any perceived benefits. Patient access and rights must take precedence over expediency.” The post Kentucky: Governor Signs Legislation Expediting Medical Cannabis Licensing, But Also Adding New Restrictions Upon Patients’ Access appeared first on NORML.
"These findings belie that claim that cannabis is a so-called 'gateway drug' and reinforces the notion that, for many individuals and for patients especially, it acts as a exit drug." The post Analysis: Medical Cannabis Associated With Decreased Use Of Opioids, Alcohol, And Tobacco appeared first on NORML.
The legislation provides discretion to physicians to issue medical cannabis recommendations to any patient who may benefit from it. It also allows those ages 65 or older to self-certify for a registration card absent a doctor’s recommendation. The post Delaware: Lawmakers Advance Medical Cannabis Expansion Bill to Governor’s Desk appeared first on NORML.
SAN DIEGO–(BUSINESS WIRE)–Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), announced today that its network marketing division, Kannaway, has completed an Asset Purchase Agreement with eXfuse, LLC, dba KZ1 a Japan based network marketing company. The KZ1 acquisition will increase the sales force of the Company’s Kannaway division in Japan by approximately 1,450 individuals and the Company The post Medical Marijuana, Inc. Kannaway Division Completes Acquisition of KZ1 Network Marketing Company appeared first on Medical Marijuana, Inc..
World’s First-Ever Publicly Traded Cannabis Company Appoints Longtime Board Member as New CEO SAN DIEGO, CA – March 14, 2023 – Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), a holding company with operating assets dedicated to the cannabis and hemp industries, along with portfolio investments in companies in the biotechnology industry, announced today the appointment The post Medical Marijuana, Inc. Appoints New CEO; Highlights Renewed Focus on Profitability, Further Expansion appeared first on Medical Marijuana, Inc..
New Products Offer 3,000mg to 6,000mg, Will Come in Jars of 30 and 60mL, Presenting Significant Cost Savings to Rapidly Growing Brazil Market SAN DIEGO, CA – January 24 2023 – Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical The post Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Launches Two New Full Spectrum Concentrations in Brazil With Competitive Price Point appeared first on Medical Marijuana, Inc..
Direct Selling Subsidiary Taps Network Marketing Legends to Lead Communication and Information Technologies as Company Continues International Expansion San Diego, CA – (NewMediaWire ) – November 29, 2022 – Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands, and supply The post Medical Marijuana, Inc. Subsidiary Kannaway Expands Leadership Team With Appointment of Industry Veterans to Roles of Executive Vice President and Vice President of Information Technology appeared first on Medical Marijuana, Inc..
SAN DIEGO, CA, Nov. 01, 2022 (GLOBE NEWSWIRE) — via NewMediaWire – Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands, and supply chain, announced today that its subsidiary HempMeds® Brasil has been featured across several major press outlets in Brazil including an interview The post Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Celebrates Major Features Across Several Marquee Brazilian Press Outlets appeared first on Medical Marijuana, Inc..
SAN DIEGO, CA, Oct. 12, 2022 (GLOBE NEWSWIRE) — via NewMediaWire – Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands, and supply chain, announced today that its subsidiary HempMeds® Mexico collaborated with experts from the Meritorious Autonomous University of Puebla, Mexico, The post Medical Marijuana, Inc. Subsidiary HempMeds® Mexico Participates in Research Finding Promising Therapeutic Benefits of CBD in Parkinson’s Disease Treatment appeared first on Medical Marijuana, Inc..
SAN DIEGO, CA, Oct. 04, 2022 (GLOBE NEWSWIRE) — via NewMediaWire – Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands, and supply chain, announced today that it has entered into an Asset Purchase Agreement with MFINITY Global LLC, a direct-selling organization The post Medical Marijuana, Inc. Enters Into Asset Purchase Agreement With MFINITY Global LLC; Appoints MFINITY President as Kannaway President appeared first on Medical Marijuana, Inc..
Global Cannabis Company Expands Supply Chain in Europe through Agreement with Complete Hemp Technologies SAN DIEGO, CA, Sept. 08, 2022 (GLOBE NEWSWIRE) — via NewMediaWire – Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands, and supply chain, announced today that its The post Medical Marijuana, Inc. Signs Deal With Leading European Manufacturer and Distributor to Expand Channel Access to Products Throughout the Region appeared first on Medical Marijuana, Inc..
SAN DIEGO, CA, Aug. 18, 2022 (GLOBE NEWSWIRE) — via NewMediaWire — Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands, and supply chain, announced its financial results for the quarter ending June 30, 2022, and provided an overview of recent The post Medical Marijuana, Inc. Reports $7.8 Million in Net Revenue in 2022 Second Quarter Financial and Operational Results appeared first on Medical Marijuana, Inc..
SAN DIEGO, CA, Aug. 11, 2022 (GLOBE NEWSWIRE) — via NewMediaWire – Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands, and supply chain, announced today its pharmaceutical subsidiary, HM Pharma, has submitted a product dossier for its cannabidiol (CBD) products after receiving The post Medical Marijuana, Inc. Subsidiary HM Pharma Submits CBD Product Dossier; Receives Sanitary Registration in Brazil appeared first on Medical Marijuana, Inc..
GreenStar patients receive more than a physician recommendation, we guarantee patients will be educated by a highly credible staff. Our board certified marijuana physician focuses on pain management and cannabis card evaluations for patients throughout Florida, specifically Orange and Seminole Counties (Orlando, Lake Mary, Sanford, Oviedo, Winter Springs, Longwood, Casselberry, and Altamonte Springs). Located less than 1 mile off the Lake Mary I-4 exit.